Molecular Classification of Neuroendocrine Tumors of the Thymus

Strobel, 2015, Thymic neuroendocrine tumours, 234 Moran, 2000, Neuroendocrine carcinomas (carcinoid tumor) of the thymus. A clinicopathologic analysis of 80 cases, Am J Clin Pathol, 114, 100, 10.1309/3PDN-PMT5-EQTM-H0CD Gaur, 2010, Thymic neuroendocrine tumors: a SEER database analysis of 160 patients, Ann Surg, 251, 1117, 10.1097/SLA.0b013e3181dd4ec4 Filosso, 2015, Outcome of primary neuroendocrine tumors of the thymus: a joint analysis of the International Thymic Malignancy Interest Group and the European Society of Thoracic Surgeons databases, J Thorac Cardiovasc Surg, 149, 103 e2, 10.1016/j.jtcvs.2014.08.061 Pelosi, 2017, Grading lung neuroendocrine tumors: controversies in search of a solution, Histol Histopathol, 32, 223 Rindi, 2010, Nomenclature and classification of neuroendocrine neoplasms of the digestive system, 13 Basturk, 2015, The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms, Am J Surg Pathol, 39, 683, 10.1097/PAS.0000000000000408 Rindi, 2018, A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal, Mod Pathol, 31, 1770, 10.1038/s41379-018-0110-y Pelosi, 2017, Classification of pulmonary neuroendocrine tumors: new insights, Transl Lung Cancer Res, 6, 513, 10.21037/tlcr.2017.09.04 Teh, 1994, Genetic studies of thymic carcinoids in multiple endocrine neoplasia type 1, J Med Genet, 31, 261, 10.1136/jmg.31.3.261 Walch, 1998, Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization, Am J Pathol, 153, 1089, 10.1016/S0002-9440(10)65653-2 Ullmann, 2002, The position of pulmonary carcinoids within the spectrum of neuroendocrine tumors of the lung and other tissues, Genes Chromosomes Cancer, 34, 78, 10.1002/gcc.10049 Zhao, 2000, Genomic alterations in well-differentiated gastrointestinal and bronchial neuroendocrine tumors (carcinoids): marked differences indicating diversity in molecular pathogenesis, Am J Pathol, 157, 1431, 10.1016/S0002-9440(10)64780-3 Petzmann, 2001, Loss of heterozygosity on chromosome arm 11q in lung carcinoids, Hum Pathol, 32, 333, 10.1053/hupa.2001.22762 Johnen, 2003, [CGH findings in neuroendocrine tumours of the lung], Pathologe, 24, 303, 10.1007/s00292-003-0623-z Strobel, 2014, Tumor genetics and survival of thymic neuroendocrine neoplasms: a multi-institutional clinicopathologic study, Genes Chromosomes Cancer, 53, 738, 10.1002/gcc.22183 Fabbri, 2017, Thymus neuroendocrine tumors with CTNNB1 gene mutations, disarrayed ss-catenin expression, and dual intra-tumor Ki-67 labeling index compartmentalization challenge the concept of secondary high-grade neuroendocrine tumor: a paradigm shift, Virchows Arch, 471, 31, 10.1007/s00428-017-2130-2 Shoji, 2011, Thymic large-cell neuroendocrine carcinoma: a disease neglected in the ESMO guideline?, Ann Oncol, 22, 2535, 10.1093/annonc/mdr415 Li, 2009, Fast and accurate short read alignment with Burrows-Wheeler transform, Bioinformatics, 25, 1754, 10.1093/bioinformatics/btp324 Scheinin, 2014, DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly, Genome Res, 24, 2022, 10.1101/gr.175141.114 Nilsen, 2012, Copynumber: efficient algorithms for single- and multi-track copy number segmentation, BMC Genomics, 13, 591, 10.1186/1471-2164-13-591 Weiss, 2017, Tumor cell-free DNA copy number instability predicts therapeutic response to immunotherapy, Clin Cancer Res, 23, 5074, 10.1158/1078-0432.CCR-17-0231 Futreal, 2004, A census of human cancer genes, Nat Rev Cancer, 4, 177, 10.1038/nrc1299 Fernandez-Cuesta, 2014, Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids, Nat Commun, 5, 3518, 10.1038/ncomms4518 Derks, 2018, New insights into the molecular characteristics of pulmonary carcinoids and large cell neuroendocrine carcinomas, and the impact on their clinical management, J Thorac Oncol, 13, 752, 10.1016/j.jtho.2018.02.002 Simbolo, 2017, Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D, J Pathol, 241, 488, 10.1002/path.4853 Konukiewitz, 2017, Somatostatin receptor expression related to TP53 and RB1 alterations in pancreatic and extrapancreatic neuroendocrine neoplasms with a Ki67-index above 20, Mod Pathol, 30, 587, 10.1038/modpathol.2016.217 Messiaen, 1999, Exon 10b of the NF1 gene represents a mutational hotspot and harbors a recurrent missense mutation Y489C associated with aberrant splicing, Genet Med, 1, 248, 10.1097/00125817-199909000-00002 Ars, 2000, Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1, Hum Mol Genet, 9, 237, 10.1093/hmg/9.2.237 Beasley, 2003, The P16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung, Hum Pathol, 34, 136, 10.1053/hupa.2003.8 Voortman, 2010, Array comparative genomic hybridization-based characterization of genetic alterations in pulmonary neuroendocrine tumors, Proc Natl Acad Sci U S A, 107, 13040, 10.1073/pnas.1008132107 Pelosi, 2018, Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm, Virchows Arch, 472, 567, 10.1007/s00428-018-2307-3 Moritz, 2018, Structure, mechanism, and regulation of polycomb-repressive complex 2, J Biol Chem, 293, 13805, 10.1074/jbc.R117.800367 Bondgaard, 2012, Different expression of EZH2, BMI1 and Ki67 in low and high grade neuroendocrine tumors of the lung, Cancer Biomark, 11, 123, 10.3233/CBM-2012-0269 Faviana, 2018, EZH2 expression in intestinal neuroendocrine tumors, Appl Immunohistochem Mol Morphol Asiedu, 2018, Pathways impacted by genomic alterations in pulmonary carcinoid tumors, Clin Cancer Res, 24, 1691, 10.1158/1078-0432.CCR-17-0252 Gieldon, 2018, Next-generation panel sequencing identifies NF1 germline mutations in three patients with pheochromocytoma but no clinical diagnosis of neurofibromatosis type 1, Eur J Endocrinol, 178, K1, 10.1530/EJE-17-0714 Philpott, 2017, The NF1 somatic mutational landscape in sporadic human cancers, Hum Genomics, 11, 13, 10.1186/s40246-017-0109-3 de Bruin, 2014, Reduced NF1 expression confers resistance to EGFR inhibition in lung cancer, Cancer Discov, 4, 606, 10.1158/2159-8290.CD-13-0741 Arana, 2008, Low-fidelity DNA synthesis by human DNA polymerase theta, Nucleic Acids Res, 36, 3847, 10.1093/nar/gkn310 Sorbye, 2013, Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study, Ann Oncol, 24, 10.1093/annonc/mds276